Evidence map›Paper›PMID 35047887›Full record

ArticleFrontiers in medical technology2020

Enhanced Immune Responses and Protective Immunity to Zika Virus Induced by a DNA Vaccine Encoding a Chimeric NS1 Fused With Type 1 Herpes Virus gD Protein.

Lennon Ramos Pereira, Rúbens Prince Dos Santos Alves, Natiely Silva Sales, Robert Andreata-Santos, Aléxia Adrianne Venceslau-Carvalho, Samuel Santos Pereira, Maria Fernanda Castro-Amarante, Mônica Josiane Rodrigues-Jesus, Marianna Teixeira de Pinho Favaro, Rosa Maria Chura-Chambi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medical technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Lennon Ramos PereiraLaboratory of Vaccine Development, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Rúbens Prince Dos Santos AlvesLaboratory of Vaccine Development, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Natiely Silva SalesLaboratory of Vaccine Development, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Robert Andreata-SantosLaboratory of Vaccine Development, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Aléxia Adrianne Venceslau-CarvalhoLaboratory of Vaccine Development, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Samuel Santos PereiraLaboratory of Vaccine Development, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Maria Fernanda Castro-AmaranteLaboratory of Vaccine Development, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Mônica Josiane Rodrigues-JesusLaboratory of Vaccine Development, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Marianna Teixeira de Pinho FavaroLaboratory of Vaccine Development, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Rosa Maria Chura-ChambiBiotechnology Center, Institute of Energy and Nuclear Research (IPEN), São Paulo, Brazil.
Ligia MorgantiBiotechnology Center, Institute of Energy and Nuclear Research (IPEN), São Paulo, Brazil.
Luís Carlos de Souza FerreiraLaboratory of Vaccine Development, Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Universidade de São Paulo · BRNational Nuclear Energy Commission · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zika virus (ZIKV) is a globally-distributed flavivirus transmitted to humans by

Indexed as

DNA vaccineflavivirusgD proteinHSV-1NS1 proteinZika virus

Identifiers

PMID35047887
PMCPMC8757838
OpenAlexW3110048688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.